Information
About the Meeting
Recent advances in genome editing (GE) technologies have opened up exciting possibilities for treating diseases by precisely modifying patients’ genomes. Impressive results have been achieved in animal models for various genetic disorders, infectious diseases, and cancer. However, challenges remain, including inadequate integration of academic research into pharmaceutical company strategies, insufficient interest from academic institutions in regulatory science, and the lack of universal standards for risk-benefit assessment by regulatory agencies. To address public health needs, collaboration between basic and clinical research, regulatory bodies, and stakeholders is crucial.
The GenE-HumDi COST Action CA21113 aims to unite pharmaceutical companies, academic institutions, regulatory agencies, biotechnology firms, patient advocacy associations, information technology and emerging scientific insights to accelerate the translation of GE technologies for human disease treatment. In this year’s international meeting in Limassol, Cyprus, we will receive updates on the latest developments in GE research, technology and tools, on pre-clinical and clinical therapeutic application, and on successful commercialization of GE technology. With plenty of scope to also sample the sights and tastes of Cyprus, the event will combine a one-day conference showcasing recent achievements and young researchers, with two days of discussion by leading EU stakeholders to tackle challenges and solutions toward routine clinical application of GE technology.
Acknowledgement
This conference and meeting is based on support by COST (European Cooperation in Science and Technology) for COST Action CA21113 (Gene Editing for the Therapy of Human Diseases, GenE-HumDi), CA21113 is jointly coordinated by
Karim Benabdel Lah, Fundación Progreso y Salud, Consejería de Salud y Consumo, Spain
Alessia Cavazza, University College London, UK
COST description
COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.
Local Organising Committee
Carsten W Lederer - The Cyprus Institute of Neurology & Genetics
Petros Patsali - The Cyprus Institute of Neurology & Genetics
Scientific Committee
See the members of the Committee here.
Event Dates & Venue
The Meeting and Workshop will take place on the 8-10 April 2024 at Pefkos City Hotel, Limassol, Cyprus.
Who can attend
Participation in the event is free. Day 1 is open for the general audience, whereas Days 2 & 3 are only open for Participants of COST Action CA21113.
Participation Cost
The selection and criteria for reimbursing meeting participants will be in line with COST Principles, notably the Excellence and Inclusiveness Policy (see Annotated rules of COST actions).
Please, note that given the large size of our Action (>250 CA21113 WG members), not all members can be funded by our Action for their attendance of this meeting.
Eligibility for funding has been determined based on each member’s active involvement and participation to WG activities to date, by following the recommendations of each Working Group (WG) leader in the selection process. Selected members are expected to significantly contribute to the deliverables and activities of each WG during and after the meeting. This is in line with the goals outlined during the GenE-HumDi annual presentation and ensures a cost effective and fair use of the available funding.
Twenty further members will be selected for funding and oral/ poster presentation based on the evaluation of the submitted abstract, where the sole criterion for selection will be its scientific quality.
Action members eligible for reimbursement will receive a formal invitation from the COST portal.
Certificates of Attendance
Certificates of attendance will be issued after the event, based on confirmation by signatures on site and/or attendance log.
Abstract Submissions
Abstract submission is now open through the event registration page until Midnight 1 March 2024.
Invites for coverage of expenses through COST CA21113, based on abstract evaluation, will be sent out to the corresponding authors by 14 March 2024.
Abstracts received after this deadline will not be considered.
Abstracts should be submitted in clear English and follow the format and content guidelines:
- Abstract as follows:
-
- Title with max 150 characters
- max 500 words; with subheadings in bold, normal-case font
- Sections to be included: Introduction | Material & Methods | Results | Discussion & Conclusions
- May include literature references within the word limit, but figures and tables will not be supported.
-
- Posters should be provided to the Meeting Secretariat by 8 April 10:00 h, in printed form, portrait orientation, Size A0 (1189mm (118.9cm) x 841mm (84.1cm)), minimum final Font Size 32.
- Format for abstracts should be DOCX to allow editing and format adjustments.
- See below Abstract template
Accommodation
You can book your accommodation directly with Pefkos City Hotel, our meeting venue, claiming the below special rates. Send an email to the hotel reservations desk, [email protected], mentioning the code CA21113.
Single Standard Room, Bed and Breakfast - €66.00 per night
Single Superior Room, Bed and Breakfast - €78.00 per night
Twin Standard Room, Bed and Breakfast - €79.00 per night
Twin Superior Room, Bed and Breakfast - €90.00 per night
About the Destination
Visitors arriving in Cyprus by air may enter the Republic of Cyprus only through the International Airports of Larnaka and Pafos for eligibility for potential reimbursement.
You can travel from the Airports to Limassol, either by bus or by taxi. You can see more information regarding travelling by bus here. Alternatively, see live bus updates in Moovit App!
Interested to know more about Limassol? Have a look in the official Love Cyprus website, or the Limassol Tourism site!
